Aprepitant Capsules and Ibritumomab
Determining the interaction of Aprepitant Capsules and Ibritumomab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Ibritumomab Intravenous
- Aprepitant Capsules-Ibritumomab Tiuxetan
- Aprepitant Capsules-Ibrutinib
- Aprepitant Capsules-Ibrutinib Capsules
- Aprepitant Capsules-Ibrutinib Tablets
- Aprepitant Capsules-Ibu
- Ibritumomab-Aprepitant Injection
- Ibritumomab-Aprepitant Intravenous
- Ibritumomab-Aprepitant Oral Suspension
- Ibritumomab-Aprepitant/Fosaprepitant Dimeglumine
- Ibritumomab-Apresazide
- Ibritumomab-Apresoline